The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, but its future within the broader market now triggers questions about future yields . Alternative versions are eroding exclusivity , prompting worries that investing in companies heavily reliant to Viagra's former standing could be a problematic mo… Read More